首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Controlling gene expression by zinc(II)-macrocyclic tetraamine complexes
【24h】

Controlling gene expression by zinc(II)-macrocyclic tetraamine complexes

机译:锌(II)-大环四胺配合物控制基因表达

获取原文
获取原文并翻译 | 示例
           

摘要

The zinc(II) complexes of 12-membered macrocyclic tetraamines (1,4,7,10-tetraazacyclododecane, cyclen) appended with one or two aryl-methyl group(s) (quinolyl-methyl, naphthyl-methyl, and acridinyl-methyl) selectively bind to thymines in a TATA box of the SV40 early promoter region and thus inhibit the binding of a transcriptional factor, TATA binding protein. These Zn2+-cyclen derivatives also act as inhibitors of DNA-targeted enzymes, type I and type II topoisomerases. They also exhibited strong antimicrobial activities for the Grampositive bacterial strain. These biochemical and biological properties were compared with those of conventionally established AT-recognizing drugs, distamycin A and DAPI. The Zn2+-cyclen complexes are a new type of small molecular, genetic transcriptional regulation factor. (C) 2000 Elsevier Science Inc. All rights reserved. [References: 39]
机译:12元大环四胺(1,4,7,10-四氮杂环十二烷,环己烯)的锌(II)配合物,附加有一个或两个芳基甲基(喹啉基甲基,萘基甲基和a啶基甲基) )在SV40早期启动子区域的TATA盒中选择性结合胸腺嘧啶,从而抑制转录因子TATA结合蛋白的结合。这些Zn2 +-环素衍生物还可以作为DNA靶向酶(I型和II型拓扑异构酶)的抑制剂。它们还对革兰氏阳性菌菌株表现出强大的抗菌活性。将这些生化和生物学特性与常规建立的AT识别药物,双霉素A和DAPI进行比较。 Zn2 +-细胞周期蛋白复合物是一种新型的小分子遗传转录调控因子。 (C)2000 Elsevier Science Inc.保留所有权利。 [参考:39]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号